Author:
de Barros Fernandes Thais,Ramos Sheila Feitosa,Leitzke Luísa Rodrigues Furtado,Júnior Ronaldo Gomes Alexandre,de Araújo Janaína Morais,de Souza Júnior Alcidésio Sales,da Silva Alice Ramos Oliveira,Heineck Isabela,de França Fonteles Marta Maria,Bracken Louise E.,Peak Matthew,de Lyra Junior Divaldo Pereira,Osorio-de-Castro Claudia G S,Lima Elisangela Costa
Abstract
AbstractThe use of antimicrobials (AMs) in pediatric infections is common practice and use may be inappropriate leading to antimicrobial resistance. Off-label AM use is also common in this group and can result in drug-related problems. There is lack of DUR data in Brazil and in Latin America, specially for AM pediatric use. The aim of this study was to describe the utilization of AMs in hospitalized children in five hospitals in Brazil. We conducted an observational study of the utilization of AMs in pediatric wards in hospitals in the states of Ceará (CE), Sergipe (SE), Rio de Janeiro (RJ), Rio Grande do Sul (RS) and the Federal District (DF). Data derived from patient medical records and prescriptions were collected over a six-month period in each hospital. The number of AMs used by each patient was recorded, and AM use was assessed using Days of therapy (DOT) and Length of therapy (LOT) per 1000 patient days according to different patient characteristics. Off-label (OL) use was described according to age. The study analyzed data from 1020 patients. The sex and age distributions were similar across the five hospitals. However, differences were found for comorbidities, history of ICU admission and length of hospital stay. The most common diseases were respiratory tract infections. There were wide variations in DOT/1000PD (278–517) and LOT/1000PD (265–390). AM utilization was highest in the hospital in SE. The consumption of second-generation penicillins and cephalosporins was high. The prevalence of OL use of AMs was higher for patients in the RJ hospital, in infants, in patients who underwent prolonged hospital stays, and in patients who used multiple AMs. The AM that showed the highest prevalence of OL use was azithromycin, in both oral and parenteral formulations. Overall AM use was high and showed differences in each setting, possibly influenced by local characteristics and by prescribing standards adopted by pediatricians.
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2022 [Internet]. Geneva. 2022 [cited 2023 Mar 30] p. 82. Available from: https://www.who.int/publications/i/item/9789240062702.
2. Rashed AN, Wong ICK, Wilton L, Tomlin S, Neubert A. Drug utilisation patterns in children admitted to a Paediatric General Medical Ward in five countries. Drugs - Real World Outcomes. 2015;2(4):397–410.
3. Griffith HG, Dantuluri K, Thurm C, Williams DJ, Banerjee R, Howard LM, et al. Considerable variability in antibiotic use among US children’s hospitals in 2017–2018. Infect Control Hosp Epidemiol. 2020;41(5):571–8.
4. Neubert A, Taxis K, Wong ICK. Drug utilization in the paediatric population. In: Elseviers M, editor. Drug utilization research: methods and applications. Wiley; 2016. pp. 248–58.
5. Allen HC, Garbe MC, Lees J, Aziz N, Chaaban H, Miller JL, et al. Off-label medication use in children, more common than we think. A Systematic Review of the Literature; 2019.